Stem Cell Therapy Market – by Treatment,Application,End Users and Geography Forecast To 2026

Stem Cell Therapy Market – by Treatment,Application,End Users and Geography Forecast To 2026

Market Scenario

Stem Cell Therapy Market is expected to reach 202.77 billion by 2026 from XX billion in 2018 at CAGR of XX %. Stands for use of stem cells to treat or prevent disease or condition.Bone marrow transplant and some therapies derived from umbilical cord blood are mainly used in stem cell therapy. Advancement, in order to establish new sources for stem cells, and to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes, heart disease, and other conditions, are increased in recent years. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Stem Cell Therapy Market Researchers are making efforts to discover novel methods to create human stem cells. This will increase the demand as well as supply for stem cell production and potential investigation in disease management. Increasing investment & research grants for developing safe and effective stem cell therapy products, the growing patient base for target diseases, concentrated product pipelines, increasing approval of the new clinical trials, rapid technological advancement in genomics, and the rising awareness about the stem cell are expected to drive the growth of the Stem Cell Therapy solutions market during the forecast period. However, improper infrastructure, insufficient storage systems, nascent technology in underdeveloped economies, Ethical issues related to an embryonic stem cell, low patient acceptance rate, Difficulty in the preservation of stem cell are expected to restrain the market growth. North America is expected to be the largest growing region by 2026; the reason behind that is extensive funding by Government. However, Emerging countries like India, china, Korea have low growth rate as compared to Developed regions in 2017 but increase in awareness about stem cell therapy will lead the Asia Pacific to generate a significant level of revenue by 2026. Key Highlights of Stem Cell Therapy Market report •Detailed quantitative analysis of the current and future trends from 2017 to 2026, which helps to identify the prevailing market opportunities. •Comprehensive analysis of factors instrumental in changing the market scenario, rising prospective opportunities, market shares, core competencies in terms of market development, growth strategies and identification of key companies that can influence this market on a global and regional scale. •Assessment of Market definition along with the identification of key drivers, restraints opportunities and challenges for this market during the forecast period. •Complete analysis of micro-markets with respect to individual growth trends, prospects, and contributions to the overall Stem Cell Therapy Solutions market. •Stem Cell Therapy market analysis and comprehensive segmentation with respect to the Application, End users, Treatment, and geography to assist in strategic business planning. •Stem Cell Therapy market analysis and forecast for five major geographies-North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions. For company profiles, 2017 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at a global market value for the stem cell therapy market.

Key Players in the Stem Cell Therapy Market are:

•Chiesi Farmaceutici S.P.A Are: •Gamida Cell •ReNeuron Group, plc •Osiris Therapeutics, Inc. •Stem Cells, Inc. •Vericel Corporation. •Mesoblast, Ltd. Key Target Audience: •Stem Cell Associations and Organizations •Government Research Boards and Organizations •Research and consulting firms •Stem Cell Therapy Market Investors •Healthcare Service Providers (including Hospitals and Diagnostic Centers) •Stem Cell Therapeutic Product Manufacturing Organizations •Research Labs •Clinical research organizations (CROs) •Stem Cell Therapy Marketing Players •Pharmaceutical Product Manufacturing Companies

Scope of the Stem Cell Therapy Market Report:

Stem Cell Therapy market research report categorizes the Stem Cell Therapy market based on Application, End users, Treatment, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Stem Cell Therapy market with key developments in companies and market trends.

Stem Cell Therapy Market, By Treatments:

•Allogeneic Stem Cell Therapy •Autologous Stem Cell Therapy Stem Cell Therapy Market, By End Users: •Hospitals •Ambulatory Surgical Centers Stem Cell Therapy Market, By Application: •Oncology •Central Nervous System Diseases •Eye Diseases •Musculoskeletal Diseases •Wound & Injuries •Metabolic Disorders •Cardiovascular Disorders •Immune System Disorders

Stem Cell Therapy Market, By Geography:

•North America •Europe •Asia Pacific •Middle East & Africa •Latin America Available Customization: With the given market data, Maximize Market Research offers customization of report and scope of the report as per the requirement Regional Analysis: •Breakdown of the North America stem cell therapy market •Breakdown of the Europe stem cell therapy market •Breakdown of the Asia Pacific stem cell therapy market •Breakdown of the Middle East & Africa stem cell therapy market •Breakdown of the Latin America stem cell therapy market Company Information: •Detailed analysis and profiles of addition

Table of Contents

Global Stem Cell Therapy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Stem Cell Therapy Market Size, by Market Value (US$ Bn ) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicators 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Stem Cell Therapy Market Analysis and Forecast 6.1. Global Stem Cell Therapy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Stem Cell Therapy Market Analysis and Forecast, by Treatments 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Stem Cell Therapy Market Value Share Analysis, by Treatments 7.4. Global Stem Cell Therapy Market Size (US$ Bn ) Forecast, by Treatments 7.5. Global Stem Cell Therapy Market Analysis, by Treatments 7.6. Global Stem Cell Therapy Market Attractiveness Analysis, by Treatments 8. Global Stem Cell Therapy Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Stem Cell Therapy Market Value Share Analysis, by Application 8.4. Global Stem Cell Therapy Market Size (US$ Bn ) Forecast, by Application 8.5. Global Stem Cell Therapy Market Analysis, by Application 8.6. Global Stem Cell Therapy Market Attractiveness Analysis, by Application 9. Global Stem Cell Therapy Market Analysis and Forecast, By End Users 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Stem Cell Therapy Market Value Share Analysis, By End Users 9.4. Global Stem Cell Therapy Market Size (US$ Bn ) Forecast, By End Users 9.5. Global Stem Cell Therapy Market Analysis, By End Users 9.6. Global Stem Cell Therapy Market Attractiveness Analysis, By End Users 10. Global Stem Cell Therapy Market Analysis, by Region 10.1. Global Stem Cell Therapy Market Value Share Analysis, by Region 10.2. Global Stem Cell Therapy Market Size (US$ Bn ) Forecast, by Region 10.3. Global Stem Cell Therapy Market Attractiveness Analysis, by Region 11. North America Stem Cell Therapy Market Analysis 11.1. Key Findings 11.2. North America Stem Cell Therapy Market Overview 11.3. North America Stem Cell Therapy Market Value Share Analysis, by Treatments 11.4. North America Stem Cell Therapy Market Forecast, by Treatments 11.4.1. Allogeneic Stem Cell Therapy 11.4.2. Autologous Stem Cell Therapy 11.5. North America Stem Cell Therapy Market Value Share Analysis, by Application 11.6. North America Stem Cell Therapy Market Forecast, by Application 11.6.1. Oncology 11.6.2. Eye Diseases 11.6.3. Musculoskeletal Diseases 11.6.4. Wound & Injuries 11.6.5. Metabolic Disorders 11.6.6. Cardiovascular Disorders 11.6.7. Immune System Disorders 11.7. North America Stem Cell Therapy Market Value Share Analysis, By End Users 11.8. North America Stem Cell Therapy Market Forecast, By End Users 11.8.1. Hospitals 11.8.2. Ambulatory Surgical Centers 11.9. North America Stem Cell Therapy Market Value Share Analysis, by Country 11.10. North America Stem Cell Therapy Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Stem Cell Therapy Market Analysis, by Country 11.12. U.S. Stem Cell Therapy Market Forecast, by Treatments 11.12.1. Allogeneic Stem Cell Therapy 11.12.2. Autologous Stem Cell Therapy 11.13. U.S. Stem Cell Therapy Market Forecast, by Application 11.13.1. Oncology 11.13.2. Eye Diseases 11.13.3. Musculoskeletal Diseases 11.13.4. Wound & Injuries 11.13.5. Metabolic Disorders 11.13.6. Cardiovascular Disorders 11.13.7. Immune System Disorders 11.14. U.S. Stem Cell Therapy Market Forecast, By End Users 11.14.1. Hospitals 11.14.2. Ambulatory Surgical Centers 11.15. Canada Stem Cell Therapy Market Forecast, by Treatments 11.15.1. Allogeneic Stem Cell Therapy 11.15.2. Autologous Stem Cell Therapy 11.16. Steel Canada Stem Cell Therapy Market Forecast, by Application 11.16.1. Oncology 11.16.2. Eye Diseases 11.16.3. Musculoskeletal Diseases 11.16.4. Wound & Injuries 11.16.5. Metabolic Disorders 11.16.6. Cardiovascular Disorders 11.16.7. Immune System Disorders 11.17. Canada Stem Cell Therapy Market Forecast, By End Users 11.17.1. Hospitals 11.17.2. Ambulatory Surgical Centers 11.18. North America Stem Cell Therapy Market Attractiveness Analysis 11.18.1. By Treatments 11.18.2. By Application 11.18.3. By End Users 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Stem Cell Therapy Market Analysis 12.1. Key Findings 12.2. Europe Stem Cell Therapy Market Overview 12.3. Europe Stem Cell Therapy Market Value Share Analysis, by Treatments 12.4. Europe Stem Cell Therapy Market Forecast, by Treatments 12.4.1. Allogeneic Stem Cell Therapy 12.4.2. Autologous Stem Cell Therapy 12.5. Europe Stem Cell Therapy Market Value Share Analysis, by Application 12.6. Europe Stem Cell Therapy Market Forecast, by Application 12.6.1. Oncology 12.6.2. Eye Diseases 12.6.3. Musculoskeletal Diseases 12.6.4. Wound & Injuries 12.6.5. Metabolic Disorders 12.6.6. Cardiovascular Disorders 12.6.7. Immune System Disorders 12.7. Europe Stem Cell Therapy Market Value Share Analysis, By End Users 12.8. Europe Stem Cell Therapy Market Forecast, By End Users 12.8.1. Hospitals 12.8.2. Ambulatory Surgical Centers 12.9. Europe Stem Cell Therapy Market Value Share Analysis, by Country 12.10. Europe Stem Cell Therapy Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Stem Cell Therapy Market Analysis, by Country 12.12. Germany Stem Cell Therapy Market Forecast, by Treatments 12.12.1. Allogeneic Stem Cell Therapy 12.12.2. Autologous Stem Cell Therapy 12.13. Germany Stem Cell Therapy Market Forecast, by Application 12.13.1. Oncology 12.13.2. Eye Diseases 12.13.3. Musculoskeletal Diseases 12.13.4. Wound & Injuries 12.13.5. Metabolic Disorders 12.13.6. Cardiovascular Disorders 12.13.7. Immune System Disorders 12.14. Germany Stem Cell Therapy Market Forecast, By End Users 12.14.1. Hospitals 12.14.2. Ambulatory Surgical Centers 12.15. U.K. Stem Cell Therapy Market Forecast, by Treatments 12.15.1. Allogeneic Stem Cell Therapy 12.15.2. Autologous Stem Cell Therapy 12.16. U.K. Stem Cell Therapy Market Forecast, by Application 12.16.1. Oncology 12.16.2. Eye Diseases 12.16.3. Musculoskeletal Diseases 12.16.4. Wound & Injuries 12.16.5. Metabolic Disorders 12.16.6. Cardiovascular Disorders 12.16.7. Immune System Disorders 12.17. U.K. Stem Cell Therapy Market Forecast, By End Users 12.17.1. Hospitals 12.17.2. Ambulatory Surgical Centers 12.18. France Stem Cell Therapy Market Forecast, by Treatments 12.18.1. Allogeneic Stem Cell Therapy 12.18.2. Autologous Stem Cell Therapy 12.19. France Stem Cell Therapy Market Forecast, by Application 12.19.1. Oncology 12.19.2. Eye Diseases 12.19.3. Musculoskeletal Diseases 12.19.4. Wound & Injuries 12.19.5. Metabolic Disorders 12.19.6. Cardiovascular Disorders 12.19.7. Immune System Disorders 12.20. France Stem Cell Therapy Market Forecast, By End Users 12.20.1. Hospitals 12.20.2. Ambulatory Surgical Centers 12.21. Italy Stem Cell Therapy Market Forecast, by Treatments 12.21.1. Allogeneic Stem Cell Therapy 12.21.2. Autologous Stem Cell Therapy 12.22. Italy Stem Cell Therapy Market Forecast, by Application 12.22.1. Oncology 12.22.2. Eye Diseases 12.22.3. Musculoskeletal Diseases 12.22.4. Wound & Injuries 12.22.5. Metabolic Disorders 12.22.6. Cardiovascular Disorders 12.22.7. Immune System Disorders 12.23. Italy Stem Cell Therapy Market Forecast, By End Users 12.23.1. Hospitals 12.23.2. Ambulatory Surgical Centers 12.24. Spain Stem Cell Therapy Market Forecast, by Treatments 12.24.1. Allogeneic Stem Cell Therapy 12.24.2. Autologous Stem Cell Therapy 12.25. Spain Stem Cell Therapy Market Forecast, by Application 12.25.1. Oncology 12.25.2. Eye Diseases 12.25.3. Musculoskeletal Diseases 12.25.4. Wound & Injuries 12.25.5. Metabolic Disorders 12.25.6. Cardiovascular Disorders 12.25.7. Immune System Disorders 12.26. Spain Stem Cell Therapy Market Forecast, By End Users 12.26.1. Hospitals 12.26.2. Ambulatory Surgical Centers 12.27. Rest of Europe Stem Cell Therapy Market Forecast, by Treatments 12.27.1. Allogeneic Stem Cell Therapy 12.27.2. Autologous Stem Cell Therapy 12.28. Rest of Europe Stem Cell Therapy Market Forecast, by Application 12.28.1. Oncology 12.28.2. Eye Diseases 12.28.3. Musculoskeletal Diseases 12.28.4. Wound & Injuries 12.28.5. Metabolic Disorders 12.28.6. Cardiovascular Disorders 12.28.7. Immune System Disorders 12.29. Rest Of Europe Stem Cell Therapy Market Forecast, By End Users 12.29.1. Hospitals 12.29.2. Ambulatory Surgical Centers 12.30. Europe Stem Cell Therapy Market Attractiveness Analysis 12.30.1. By Treatments 12.30.2. By Application 12.30.3. By End Users 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Stem Cell Therapy Market Analysis 13.1. Key Findings 13.2. Asia Pacific Stem Cell Therapy Market Overview 13.3. Asia Pacific Stem Cell Therapy Market Value Share Analysis, by Treatments 13.4. Asia Pacific Stem Cell Therapy Market Forecast, by Treatments 13.4.1. Allogeneic Stem Cell Therapy 13.4.2. Autologous Stem Cell Therapy 13.5. Asia Pacific Stem Cell Therapy Market Value Share Analysis, by Application 13.6. Asia Pacific Stem Cell Therapy Market Forecast, by Application 13.6.1. Oncology 13.6.2. Eye Diseases 13.6.3. Musculoskeletal Diseases 13.6.4. Wound & Injuries 13.6.5. Metabolic Disorders 13.6.6. Cardiovascular Disorders 13.6.7. Immune System Disorders 13.7. Asia Pacific Stem Cell Therapy Market Value Share Analysis, By End Users 13.8. Asia Pacific Stem Cell Therapy Market Forecast, By End Users 13.8.1. Hospitals 13.8.2. Ambulatory Surgical Centers 13.9. Asia Pacific Stem Cell Therapy Market Value Share Analysis, by Country 13.10. Asia Pacific Stem Cell Therapy Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Stem Cell Therapy Market Analysis, by Country 13.12. China Stem Cell Therapy Market Forecast, by Treatments 13.12.1. Allogeneic Stem Cell Therapy 13.12.2. Autologous Stem Cell Therapy 13.13. China Stem Cell Therapy Market Forecast, by Application 13.13.1. Oncology 13.13.2. Eye Diseases 13.13.3. Musculoskeletal Diseases 13.13.4. Wound & Injuries 13.13.5. Metabolic Disorders 13.13.6. Cardiovascular Disorders 13.13.7. Immune System Disorders 13.14. China Stem Cell Therapy Market Forecast, By End Users 13.14.1. Hospitals 13.14.2. Ambulatory Surgical Centers 13.15. India Stem Cell Therapy Market Forecast, by Treatments 13.15.1. Allogeneic Stem Cell Therapy 13.15.2. Autologous Stem Cell Therapy 13.16. India Stem Cell Therapy Market Forecast, by Application 13.16.1. Oncology 13.16.2. Eye Diseases 13.16.3. Musculoskeletal Diseases 13.16.4. Wound & Injuries 13.16.5. Metabolic Disorders 13.16.6. Cardiovascular Disorders 13.16.7. Immune System Disorders 13.17. India Stem Cell Therapy Market Forecast, By End Users 13.17.1. Hospitals 13.17.2. Ambulatory Surgical Centers 13.18. Japan Stem Cell Therapy Market Forecast, by Treatments 13.18.1. Allogeneic Stem Cell Therapy 13.18.2. Autologous Stem Cell Therapy 13.19. Japan Stem Cell Therapy Market Forecast, by Application 13.19.1. Oncology 13.19.2. Eye Diseases 13.19.3. Musculoskeletal Diseases 13.19.4. Wound & Injuries 13.19.5. Metabolic Disorders 13.19.6. Cardiovascular Disorders 13.19.7. Immune System Disorders 13.20. Japan Stem Cell Therapy Market Forecast, By End Users 13.20.1. Hospitals 13.20.2. Ambulatory Surgical Centers 13.21. ASEAN Stem Cell Therapy Market Forecast, by Treatments 13.21.1. Allogeneic Stem Cell Therapy 13.21.2. Autologous Stem Cell Therapy 13.22. ASEAN Stem Cell Therapy Market Forecast, by Application 13.22.1. Oncology 13.22.2. Eye Diseases 13.22.3. Musculoskeletal Diseases 13.22.4. Wound & Injuries 13.22.5. Metabolic Disorders 13.22.6. Cardiovascular Disorders 13.22.7. Immune System Disorders 13.23. ASEAN Stem Cell Therapy Market Forecast, By End Users 13.23.1. Hospitals 13.23.2. Ambulatory Surgical Centers 13.24. Rest of Asia Pacific Stem Cell Therapy Market Forecast, by Treatments 13.24.1. Allogeneic Stem Cell Therapy 13.24.2. Autologous Stem Cell Therapy 13.25. Rest of Asia Pacific Stem Cell Therapy Market Forecast, by Application 13.25.1. Oncology 13.25.2. Eye Diseases 13.25.3. Musculoskeletal Diseases 13.25.4. Wound & Injuries 13.25.5. Metabolic Disorders 13.25.6. Cardiovascular Disorders 13.25.7. Immune System Disorders 13.26. Rest of Asia Pacific Stem Cell Therapy Market Forecast, By End Users 13.26.1. Hospitals 13.26.2. Ambulatory Surgical Centers 13.27. Asia Pacific Stem Cell Therapy Market Attractiveness Analysis 13.27.1. By Treatments 13.27.2. By Application 13.27.3. By End Users 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Stem Cell Therapy Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Stem Cell Therapy Market Overview 14.3. Middle East & Africa Stem Cell Therapy Market Value Share Analysis, by Treatments 14.4. Middle East & Africa Stem Cell Therapy Market Forecast, by Treatments 14.4.1. Allogeneic Stem Cell Therapy 14.4.2. Autologous Stem Cell Therapy 14.5. Middle East & Africa Stem Cell Therapy Market Value Share Analysis, by Application 14.6. Middle East & Africa Stem Cell Therapy Market Forecast, by Application 14.6.1. Oncology 14.6.2. Eye Diseases 14.6.3. Musculoskeletal Diseases 14.6.4. Wound & Injuries 14.6.5. Metabolic Disorders 14.6.6. Cardiovascular Disorders 14.6.7. Immune System Disorders 14.7. Middle East & Africa Stem Cell Therapy Market Value Share Analysis, By End Users 14.8. Middle East & Africa Stem Cell Therapy Market Forecast, By End Users 14.8.1. Hospitals 14.8.2. Ambulatory Surgical Centers 14.9. Middle East & Africa Stem Cell Therapy Market Value Share Analysis, by Country 14.10. Middle East & Africa Stem Cell Therapy Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Stem Cell Therapy Market Analysis, by Country 14.12. GCC Stem Cell Therapy Market Forecast, by Treatments 14.12.1. Allogeneic Stem Cell Therapy 14.12.2. Autologous Stem Cell Therapy 14.13. GCC Stem Cell Therapy Market Forecast, by Application 14.13.1. Oncology 14.13.2. Eye Diseases 14.13.3. Musculoskeletal Diseases 14.13.4. Wound & Injuries 14.13.5. Metabolic Disorders 14.13.6. Cardiovascular Disorders 14.13.7. Immune System Disorders 14.14. GCC Stem Cell Therapy Market Forecast, By End Users 14.14.1. Hospitals 14.14.2. Ambulatory Surgical Centers 14.15. South Africa Stem Cell Therapy Market Forecast, by Treatments 14.15.1. Allogeneic Stem Cell Therapy 14.15.2. Autologous Stem Cell Therapy 14.16. South Africa Stem Cell Therapy Market Forecast, by Application 14.16.1. Oncology 14.16.2. Eye Diseases 14.16.3. Musculoskeletal Diseases 14.16.4. Wound & Injuries 14.16.5. Metabolic Disorders 14.16.6. Cardiovascular Disorders 14.16.7. Immune System Disorders 14.17. South Africa Stem Cell Therapy Market Forecast, By End Users 14.17.1. Hospitals 14.17.2. Ambulatory Surgical Centers 14.18. Rest of Middle East & Africa Stem Cell Therapy Market Forecast, by Treatments 14.18.1. Allogeneic Stem Cell Therapy 14.18.2. Autologous Stem Cell Therapy 14.19. Rest of Middle East & Africa Stem Cell Therapy Market Forecast, by Application 14.19.1. Oncology 14.19.2. Eye Diseases 14.19.3. Musculoskeletal Diseases 14.19.4. Wound & Injuries 14.19.5. Metabolic Disorders 14.19.6. Cardiovascular Disorders 14.19.7. Immune System Disorders 14.20. Rest of Middle East & Africa Stem Cell Therapy Market Forecast, By End Users 14.20.1. Hospitals 14.20.2. Ambulatory Surgical Centers 14.21. Middle East & Africa Stem Cell Therapy Market Attractiveness Analysis 14.21.1. By Treatments 14.21.2. By Application 14.21.3. By End Users 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Stem Cell Therapy Market Analysis 15.1. Key Findings 15.2. South America Stem Cell Therapy Market Overview 15.3. South America Stem Cell Therapy Market Value Share Analysis, by Treatments 15.4. South America Stem Cell Therapy Market Forecast, by Treatments 15.4.1. Allogeneic Stem Cell Therapy 15.4.2. Autologous Stem Cell Therapy 15.5. South America Stem Cell Therapy Market Value Share Analysis, by Application 15.6. South America Stem Cell Therapy Market Forecast, by Application 15.6.1. Oncology 15.6.2. Eye Diseases 15.6.3. Musculoskeletal Diseases 15.6.4. Wound & Injuries 15.6.5. Metabolic Disorders 15.6.6. Cardiovascular Disorders 15.6.7. Immune System Disorders 15.7. South America Stem Cell Therapy Market Value Share Analysis, By End Users 15.8. South America Stem Cell Therapy Market Forecast, By End Users 15.8.1. Hospitals 15.8.2. Ambulatory Surgical Centers 15.9. South America Stem Cell Therapy Market Value Share Analysis, by Country 15.10. South America Stem Cell Therapy Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Stem Cell Therapy Market Analysis, by Country 15.12. Brazil Stem Cell Therapy Market Forecast, by Treatments 15.12.1. Allogeneic Stem Cell Therapy 15.12.2. Autologous Stem Cell Therapy 15.13. Brazil Stem Cell Therapy Market Forecast, by Application 15.13.1. Oncology 15.13.2. Eye Diseases 15.13.3. Musculoskeletal Diseases 15.13.4. Wound & Injuries 15.13.5. Metabolic Disorders 15.13.6. Cardiovascular Disorders 15.13.7. Immune System Disorders 15.14. Brazil Stem Cell Therapy Market Forecast, By End Users 15.14.1. Hospitals 15.14.2. Ambulatory Surgical Centers 15.15. Mexico Stem Cell Therapy Market Forecast, by Treatments 15.15.1. Allogeneic Stem Cell Therapy 15.15.2. Autologous Stem Cell Therapy 15.16. Mexico Stem Cell Therapy Market Forecast, by Application 15.16.1. Oncology 15.16.2. Eye Diseases 15.16.3. Musculoskeletal Diseases 15.16.4. Wound & Injuries 15.16.5. Metabolic Disorders 15.16.6. Cardiovascular Disorders 15.16.7. Immune System Disorders 15.17. Mexico Stem Cell Therapy Market Forecast, By End Users 15.17.1. Hospitals 15.17.2. Ambulatory Surgical Centers 15.18. Rest of South America Stem Cell Therapy Market Forecast, by Treatments 15.18.1. Allogeneic Stem Cell Therapy 15.18.2. Autologous Stem Cell Therapy 15.19. Rest of South America Stem Cell Therapy Market Forecast, by Application 15.19.1. Oncology 15.19.2. Eye Diseases 15.19.3. Musculoskeletal Diseases 15.19.4. Wound & Injuries 15.19.5. Metabolic Disorders 15.19.6. Cardiovascular Disorders 15.19.7. Immune System Disorders 15.20. Rest of South America Stem Cell Therapy Market Forecast, By End Users 15.20.1. Hospitals 15.20.2. Ambulatory Surgical Centers 15.21. South America Stem Cell Therapy Market Attractiveness Analysis 15.21.1. By Treatments 15.21.2. By Application 15.21.3. By End Users 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Chiesi Farmaceutici S.P.A 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing Footprint 16.3.2. Gamida Cell 16.3.3. ReNeuron Group, plc 16.3.4. Osiris Therapeutics, Inc. 16.3.5. Stem Cells, Inc. 16.3.6. Vericel Corporation. 16.3.7. Mesoblast, Ltd. 17. Primary Key Insights

About This Report

Report ID522
Category Healthcare
Published Date
No of Pages215
Contact Us
Call Now